Johnson & Johnson is set to report its Q1 2018 earnings on April 17, and we expect the company to post solid numbers, primarily led by continued growth in oncology drug sales...
Johnson & Johnson is set to report its Q1 2018 earnings on April 17, and we expect the company to post solid numbers, primarily led by continued growth in oncology drug sales...